Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason S Carroll

Showing results (181-190 of 192) with videos related to

Pageof 20
Sort By:
NPJ Breast Cancer|February 18, 2022
Estrogen receptor beta repurposes EZH2 to suppress oncogenic NFκB/p65 signaling in triple negative breast cancerKirsten G M Aspros, Jodi M Carter, Tanya L Hoskin, et al.
Nature Communications|November 5, 2021
Opposing transcriptional programs of KLF5 and AR emerge during therapy for advanced prostate cancerMeixia Che, Aashi Chaturvedi, Sarah A Munro, et al.
Plos Biology|January 10, 2013
ELF5 suppresses estrogen sensitivity and underpins the acquisition of antiestrogen resistance in luminal breast cancerMaria Kalyuga, David Gallego-Ortega, Heather J Lee, et al.
Molecular Cell|May 17, 2020
Synthetic Lethal and Resistance Interactions with BET Bromodomain Inhibitors in Triple-Negative Breast CancerShaokun Shu, Hua-Jun Wu, Jennifer Y Ge, et al.
Nature Genetics|June 2, 2025
KDM4C inhibition blocks tumor growth in basal breast cancer by promoting cathepsin L-mediated histone H3 cleavageZheqi Li, Guillermo Peluffo, Laura E Stevens, et al.
Cancer Research|January 26, 2022
Hotspot ESR1 Mutations Are Multimodal and Contextual Modulators of Breast Cancer MetastasisZheqi Li, Yang Wu, Megan E Yates, et al.
Nature|January 7, 2016
Response and resistance to BET bromodomain inhibitors in triple-negative breast cancerShaokun Shu, Charles Y Lin, Housheng Hansen He, et al.
Journal of the National Cancer Institute|December 15, 2015
Choline Kinase Alpha as an Androgen Receptor Chaperone and Prostate Cancer Therapeutic TargetMohammad Asim, Charles E Massie, Folake Orafidiya, et al.
Genome Research|February 9, 2008
Systematic evaluation of variability in ChIP-chip experiments using predefined DNA targetsDavid S Johnson, Wei Li, D Benjamin Gordon, et al.
Breast Cancer Research : BCR|November 30, 2013
Critical research gaps and translational priorities for the successful prevention and treatment of breast cancerSuzanne A Eccles, Eric O Aboagye, Simak Ali, et al.
Pageof 20

Showing results (181-190 of 192) with videos related to

Sort By:
Pageof 20
NPJ Breast Cancer|February 18, 2022
Estrogen receptor beta repurposes EZH2 to suppress oncogenic NFκB/p65 signaling in triple negative breast cancerKirsten G M Aspros, Jodi M Carter, Tanya L Hoskin, et al.
Nature Communications|November 5, 2021
Opposing transcriptional programs of KLF5 and AR emerge during therapy for advanced prostate cancerMeixia Che, Aashi Chaturvedi, Sarah A Munro, et al.
Plos Biology|January 10, 2013
ELF5 suppresses estrogen sensitivity and underpins the acquisition of antiestrogen resistance in luminal breast cancerMaria Kalyuga, David Gallego-Ortega, Heather J Lee, et al.
Molecular Cell|May 17, 2020
Synthetic Lethal and Resistance Interactions with BET Bromodomain Inhibitors in Triple-Negative Breast CancerShaokun Shu, Hua-Jun Wu, Jennifer Y Ge, et al.
Nature Genetics|June 2, 2025
KDM4C inhibition blocks tumor growth in basal breast cancer by promoting cathepsin L-mediated histone H3 cleavageZheqi Li, Guillermo Peluffo, Laura E Stevens, et al.
Cancer Research|January 26, 2022
Hotspot ESR1 Mutations Are Multimodal and Contextual Modulators of Breast Cancer MetastasisZheqi Li, Yang Wu, Megan E Yates, et al.
Nature|January 7, 2016
Response and resistance to BET bromodomain inhibitors in triple-negative breast cancerShaokun Shu, Charles Y Lin, Housheng Hansen He, et al.
Journal of the National Cancer Institute|December 15, 2015
Choline Kinase Alpha as an Androgen Receptor Chaperone and Prostate Cancer Therapeutic TargetMohammad Asim, Charles E Massie, Folake Orafidiya, et al.
Genome Research|February 9, 2008
Systematic evaluation of variability in ChIP-chip experiments using predefined DNA targetsDavid S Johnson, Wei Li, D Benjamin Gordon, et al.
Breast Cancer Research : BCR|November 30, 2013
Critical research gaps and translational priorities for the successful prevention and treatment of breast cancerSuzanne A Eccles, Eric O Aboagye, Simak Ali, et al.
Pageof 20